LBO — ST ELIZABETH BOARDMAN HEALTH CTR
IRR: 16.9% | MOIC: 2.18x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.9%
IRR
2.18x
MOIC
$300.1M
Entry EV
$457.5M
Exit EV
$154.4M
Equity Invested
Sources & Uses
S&UTotal · $300.1M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $116.5M | 38.8% | |
| Sub Debt | $29.1M | 9.7% | |
| Equity | $154.4M | 51.5% | |
| Enterprise Value | $291.3M | 97.1% | |
| Transaction Fees | $8.7M | 2.9% | |
| Total Uses | $300.1M | 100.0% |
Interpretation
INTAt 2.18x MOIC and 16.9% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $43.6M |
| Exit Ev | $457.5M |
| Net Debt At Exit | $120.3M |
| Equity At Exit | $337.3M |
| Equity Invested | $154.4M |
| Total Value Created | $182.9M |
| Value From Growth | $151.6M |
| Value From Multiple | $14.6M |
| Value From Deleveraging | $25.4M |